NextGen Actives Launches Buzzy Apinol360 Propolis-derived Retinol Alternative

NextGen Actives has launched Apinol360 (INCI: PEG-8 (and) Soybean Lecithin (and) Propolis Extract), an anti-inflammaging active positioned as a natural, safe alternative to retinol.

Per the company, the ingredient offers superior anti-aging benefits without the harsh side effects of traditional retinoids, such as skin dryness and irritation. Described as an antioxidant and antimicrobial "powerhouse," the product has been clinically proven at 1.5% to reduce lines and wrinkles by more than 35% within 28 days.

The ingredient is derived from propolis, revered for its healing properties and infused with four essential phenolic components:

• p-coumaric acid,
• trans-ferulic acid,
• caffeic acid and
• caffeic acid phenethyl ester (CAPE).

ApiotiX Technologies' patented non-alcoholic extraction process is employed to ensure these bioactive compounds are isolated and preserved at the highest purity, NextGen Actives reports.

The result is a 15% concentrated solution that is "meticulously blended" in PEG-400 and lecithin to ensure the stability of Apinol360 and to enhance its delivery.

With its potent anti-inflammatory and antioxidant properties, Apinol360 is said to offer a holistic 360 approach to skin care, promoting healthy, youthful skin while addressing the growing demand for derm-like cosmetic actives. 

Furthermore, considering the European Union's recent restriction limiting retinol to 0.3%, NexGen Actives notes Apinol360 is a timely solution.